Rheumatoid arthritis

Evaluation of a web-based self-monitoring application (MyRA) to empower people with rheumatoid arthritis in daily life

Rheumatology (Oxford)Published Prospective cohort study

Authors' conclusion

Despite major patient involvement throughout development, self-monitoring via MyRA did not increase patient empowerment.

Study context

Population
Registered patients with RA (90.1% female, mean age 51.8 [SD 11.9] years, mean disease duration 10.2 [SD 10.1] years)54 never used the application
Participants
548 patients
Exposure
Before vs after 4 months of self-monitoring with MyRA (web-based application), used at patients' own discretion
  • Subgroup A (infrequent users)n = 405reference
  • Subgroup B (frequent users)n = 89
  • Never usedn = 54
Outcome
Patient empowerment (Patient Activation Measure-13; 0-100)
Follow-up
4 months
Methodological detailssingle-group, co-developed with patients, repeated measures ANOVA, post-hoc subgroup analysis by frequency of use
  • Single-group
  • Co-developed with patients
  • Repeated measures ANOVA
  • Post-hoc subgroup analysis by frequency of use

Main finding

As reported in the abstract

Patient empowerment (PAM-13; 0-100), total user group · T0 vs T2 (4 months)
Total user group, T0
55.8
Total user group, T2
54.4
No statistical difference after 4 months
P = 0.09

Observational data: associations, not effects.

Secondary outcomes

OutcomeSubgroup BSubgroup AP value
Usability (System Usability Scale; 0-100)75.962.9P < 0.001

Patient empowerment (PAM-13), subgroup B (post-hoc) · T0 vs T2 (4 months)

Subgroup B, T0
56.2
Subgroup B, T2
53.6
Statistically significant, though not clinically meaningful, decrease
P = 0.04
  • Post-hoc subgroup analysis

Perceived usefulness

Subgroup B more outspoken in perceived usefulness

Frequency of use

Never used
54 (9.9%)
Infrequent users
405 (73.9%)
Frequent users
89 (16.2%)

Original publication

Evaluation of a web-based self-monitoring application (MyRA) to empower people with rheumatoid arthritis in daily life. Rheumatology (Oxford). Published 30 October 2025. doi:10.1093/rheumatology/keaf565

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.